FLKS - Flex Pharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 57.49M
Enterprise Value 3108.61k
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)9.80
Price/Book (mrq)1.03
Enterprise Value/Revenue 30.14
Enterprise Value/EBITDA 6-0.01

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,763.19%

Management Effectiveness

Return on Assets (ttm)-49.24%
Return on Equity (ttm)-109.25%

Income Statement

Revenue (ttm)764.54k
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)-41.20%
Gross Profit (ttm)407.39k
EBITDA -13.28M
Net Income Avi to Common (ttm)-15.93M
Diluted EPS (ttm)-0.8820
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.3M
Total Cash Per Share (mrq)0.4
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.94
Book Value Per Share (mrq)0.40

Cash Flow Statement

Operating Cash Flow (ttm)-16.84M
Levered Free Cash Flow (ttm)-9.34M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.23
52-Week Change 3-89.55%
S&P500 52-Week Change 34.96%
52 Week High 34.3000
52 Week Low 30.2600
50-Day Moving Average 30.4655
200-Day Moving Average 30.4006

Share Statistics

Avg Vol (3 month) 31.18M
Avg Vol (10 day) 3261.91k
Shares Outstanding 518.07M
Float 16.74M
% Held by Insiders 113.44%
% Held by Institutions 111.68%
Shares Short (Apr 30, 2019) 41M
Short Ratio (Apr 30, 2019) 40.5
Short % of Float (Apr 30, 2019) 45.57%
Short % of Shares Outstanding (Apr 30, 2019) 45.54%
Shares Short (prior month Mar 29, 2019) 4893.41k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A